Lowest Price Guaranteed
Pages
466
Last Updated
April 2026
View Count
26847
The Exoskeleton Market is estimated to grow from USD 2.2 billion in 2024 to 2.9 billion in 2025 and USD 20.3 billion by 2035, representing a CAGR of 22.4% during the forecast period.
 |
To learn more about this report, request a free sample copy
Over time, the healthcare burden caused by neurological disorders, such as multiple sclerosis and strokes has grown substantially, in line with the increasing prevalence of these conditions. Over time, the healthcare burden caused by neurological disorders, such as multiple sclerosis and strokes has grown substantially, in line with the increasing prevalence of these conditions. According to the World Health Organization (WHO), approximately 1.8 million individuals, worldwide, currently suffer from multiple sclerosis, whereas over 12.2 million patients experience stroke, every year.
Neurological disorders often lead to muscle weakness, which affects mobility, whether in localized muscle groups (such as hemiplegia, paraplegia, or quadriplegia) or the entire body. Unfortunately, there is no cure for neuromotor impairment; however, the use of assistive ambulatory devices, such as wheelchairs, crutches, and walkers can enhance independence and comfort for patients. Though these assistive devices are widely popular, they provide short-term relief rather than a transformative solution.
Over the years, exoskeletons have emerged as a partial alternative or a companion rehabilitation device that allow individuals with spinal cord injury and related injuries to walk freely in hospital and at home compared to the conventional ambulatory options . A medical exoskeleton is a wearable electromechanical device designed to help patients with mobility issues, that are either partially or completely paralyzed, in restoring movements of upper extremity or lower extremity. Leveraging neuroplasticity, the medical exoskeleton equipped with sensors, motors, actuators, power sources and control strategies enable recovery of fundamental movements and speed up recovery from injuries, such as acquired brain injury (ABI) or spinal cord injury (SCI).
As exoskeleton technology advances and the cost of exoskeletons decreases, and the stakeholders recognize the positive return on investment (ROI) on exoskeleton products (owing to higher benefit-cost ratio), the adoption of this nascent exoskeleton technology across various industries is poised to grow, ultimately driving the growth of the global exoskeleton market during the forecast period.
| Key Report Attributes | Details | |
| Historical Trend | Since 2023 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | $ 2.9 Billion | |
| Market Size 2035 | $ 20.3 Billion | |
| CAGR (Till 2035) | 22.4% | |
The exoskeleton market analysis also features the likely distribution of the current and forecasted opportunity across various segments, such as body part covered, mode of operation, form of exoskeleton, mobility, end user and geographical regions.
We have created three market forecast scenarios, conservative, base and optimistic, to account for future uncertainties in key parameters and enhance the robustness of our model. These scenarios represent different tracks of the industry's evolution.
Medical exoskeleton has emerged as a popular rehabilitation tool, transforming the field of medical robotics. Medical exoskeletons have the ability to restore movement in individuals with motor impairments, as well as augment performance in able bodied users. The device uses sensors and actuation technologies (motors, pneumatics, levers, or hydraulics) to restore locomotion of the upper extremity and / or lower extremity. Beyond healthcare purposes, industrial exoskeleton provides postural support, improved productivity and reduces work-related injuries.
Several recent developments have taken place in the exoskeleton industry, and we have outlined some of these below. These developments, even if they arose after our market report’s release, support the overall exoskeleton market trends detailed in our analysis.
The market research report presents an in-depth analysis of the various companies designing, developing and commercializing exoskeletons across different segments, as defined in the table below:
| Market Segmentations | Details | |
| Body Part Covered |
|
|
| Mode of Operation |
|
|
| Form |
|
|
| Mobility |
|
|
| End User |
|
|
| Geographical Regions |
|
|
Owing to the recent advancements in exoskeleton technology to transition from bulky and high-cost exoskeletons to light weight and affordable exosuits, the global exoskeleton market is likely to grow at a steady rate during the forecast period.
 |
| Report Deliverables | Details | |
| Excel Data Packs (Complimentary) |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
The “Exoskeleton Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current competitive landscape, product competitiveness analysis, partnerships and collaborations, patent analysis, blue ocean strategy, market impact analysis and market size and future opportunities within the industry, during the forecast period.
 |
The current market landscape features the presence of over 95 companies that design, develop and commercialize medical exoskeleton for patients, healthcare providers and researchers. Further, over 45% of the medical exoskeleton companies are headquartered in Europe, followed by Asia-Pacific (38%).
Some examples of players engaged in manufacturing passive exoskeletons include (in alphabetical order) Archelis, Hocoma, Newndra Innovations, Mebster, Ossur and PolySpine.
The current market landscape features the presence of close to 100 non-medical exoskeleton companies engaged in manufacturing exoskeletons for industrial workers, military purposes, daily life activities, sports and agriculture. It is worth mentioning that there has been a substantial rise in the number of non-medical exoskeleton companies over the past decade, indicating significant start-up activity in the exoskeleton market.
Further, a significant proportion of the non-medical exoskeleton companies (73%) offer support to industrial workers employed in different sectors; notable examples of players engaged in manufacturing non-medical exoskeletons include (in alphabetical order) Bionic Power, CYBERDYNE, Ekso Bionics, LG Electronics, Ottobock and Xeno Dynamics.
 |
The global exoskeleton market size is likely to be worth $ 2.9 billion in 2025 and will reach $ 20.3 billion by 2035. In terms of mode of operation, powered exoskeleton segment holds the largest share of the exoskeleton market as they have emerged as a breakthrough device for rehabilitation of individuals with mobility impairments.
Further, powered exoskeletons augment the human capabilities in rehabilitation centers and home settings, allowing the subject to not only receive rehabilitation in a hospital setting but also to continue their recovery process in the community and at home.
North American companies will likely dominate the global exoskeleton market in 2035, owing to the robust regulatory activities, coupled with increasing demand for exoskeletons for various end both medical and industrial settings.
The market in Asia-Pacific is likely to grow at a relatively high CAGR (26.4%), during the forecast period till 2035. This is a result of presence of majority of exoskeleton market companies in this region coupled with rapid facility and capability expansion in developing countries.
As the global population continues to age, there is a growing need for solutions to assist people with mobility issues and age-related conditions. Medical exoskeletons can provide support to elderly individuals to maintain an active, independent lifestyle, with improved quality of life. With rising incidence of neurological disorders and related injuries, demand for mobility devices has also increased as they can alleviate the burden by providing enhanced mobility and support, allowing individuals to regain independence, and potentially slow down the disease progression.
It is worth mentioning that the applications of exoskeletons have expanded from mobility assistance in healthcare, to industrial and military sectors, where exoskeletons enable performance enhancement and reduce the risk of injuries. Their adaptability and versatility, combined with ongoing innovation, position them as a transformative technology with multifaceted potential.
Despite their several benefits, the use of exoskeletons presents several challenges. Currently, exoskeletons face competition from conventional orthotic and prosthetic devices and are not considered the standard of care in rehabilitation. Further, regulatory bodies, such as the USFDA, often rely on industry standards to evaluate and approve exoskeletons, which are considered Class II medical devices. The lack of standards can lead to inconsistencies in regulatory processes, making it more difficult for manufacturers to obtain approvals for their products, which can hinder market entry.
Additionally, design-related challenges persist with current exoskeletons, including limited range of motion and heavy weight, causing discomfort to the users’ bodies. These factors inhibit their adoption and usability. Additionally, navigation through uneven surfaces remains a hurdle, and twisting motions are yet to be developed in prototypes.
 |
In recent years, several partnerships have been inked by industry stakeholders, in order to consolidate their presence in this field. It is worth highlighting that nearly 60% of deals were forged in the last three years. Interestingly, most of the agreements were distribution agreements (26%), followed by product / technology development agreements (15%).
In March 2025, Lifeward and CorLife jointly announced that the companies have finalized an agreement for CorLife to become the exclusive distributor for the ReWalk Personal Exoskeleton for individuals with Workers’ Compensation claims.
In the past few years, more than 3,700 patents have been granted / filed, demonstrating substantial efforts of researchers in this domain. Notably, the majority of the patents in this domain include patent applications (66%), followed by granted patents (17%). Interestingly, most of the patents (49%) are filed by non-industry players in this field.
Recent advancements in exoskeleton technology with the integration of modern tools, have paved way for remarkable innovations in the medical exoskeletons for stroke rehabilitation. Few exoskeleton companies have developed / are currently developing AI-enables exoskeleton models which can be used to enhance physical performance during a wide range of activities, especially for outdoor enthusiasts and individuals seeking improved mobility. For instance, in January 2025, Hypershell’s Carbon X-powered hip exoskeleton for hiking and exercise received a 2025 Best of Innovation in Robotics recognition.
Several exoskeleton companies are slowly transitioning from bulky and high-cost exoskeletons to light weight and affordable exosuits with human-like anthropomorphic designs. For instance, Hilti Bionic Arm, an industrial exoskeleton, weighs only 5 pounds and is developed for assisting workers in carrying out overhead tasks conveniently.
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the exoskeleton industry, across different geographies. Amongst other elements, the market report includes:
The exoskeleton market is rapidly expanding as these advanced wearable devices find growing application in industries such as manufacturing, construction and logistics, where they help workers perform physically demanding tasks with reduced fatigue and lower risk of injury. Moreover, technological innovations are continually improving exoskeletons, making them lighter, more adaptable and easier to use, which is further driving adoption across various sectors. Additionally, ongoing efforts to reduce the cost of medical exoskeletons, driven by material and technological advancements and government support, contribute to this positive outlook.
Lead Author: Manika Goyal
Lead Reviewer: Dhriti Gulati
Chief Editor: Prachi Bhalla